- D. Bauer, A. Farthofer, D. Chromy, B. Simbrunner, L. Steininger, C. Schmidbauer, T. Binter, M. Trauner, M. Mandorfer, R. Schmidt, F. Mayer, H. Holzmann, R. Strassl, T. Reiberger. Recent outbreaks of severe Hepatitis A Virus infections in Vienna. Eur J Clin Microbiol Infect Dis 2020
- FV. Bruschi, M. Tardelli. M. Herac, T. Claudel, M. Trauner. Metabolic Regulation of hepatic PNPLA3 Expression and severity of liver fibrosis in patients with NASH. Liver Int. 2020; 40(5):1098-1110
- K. Brusilovskaya, P. Königshofer, D. Lampach, A. Szodl, P. Supper, D. Bauer, A. Beer, J. Stift, G. Timelthaler, G. Oberhuber, BK. Podesser, M. Seif, K. Zinober, N. Rohr-Udilova, M. Trauner, T. Reiberger, P. Schwabl. Soluble guanylyl cyclase Stimulation and phosphodiesterase-5 Inhibition improve Portal Hypertension and reduce liver fibrosis in bile duct ligated rats. United European Gastroenterol J 2020
- E. Fabian, HP. Gröchenig, PK. Bauer, AJ. Eherer, M. Gugatschka, L. Binder, C. Langner, P. Fickert, GJ. Krejs. Clinical-Pathological Conference Series from the Medical University of Graz. Case No 171: A 37 year old engineer with Bolus hold up (esophageal Food impaction). Wien Klin. Wochenschr 2020
- E. Fabian, C. Tinchon, A. Lueger, PK. Bauer, Kl. Mayer-Pickel, RB. Raggam, HF. Hammer, C. Langner, GJ. Krejs. Clinical Pathological Conference Series from the Medical University of Graz. Case No 169: A 32 year old woman with anemia in pregnancy. Wien Klein. Wochenschr 2020, 132(11-12):322-331.
- C. Espinos. P. Ferenci. Are the new genetic Tools for diagnosis of Wilson disease helpful in clinical practice? JHep Rep 2020, 18;2(4):100114
- P. Ferenci, Are all cirrhotic patients equal? J Hep 2020; 72(3):389-390
- CD. Fuchs, S. Krivanec, D. Steinacher, V. Mlitz, A. Wahlström, M. Stahlman, T. Claudel, H. Scharnagl, T. Stojakovic, HU. Marschall, M. Trauner. Absence of Bsep/Abcb11 attenuates MCD-diet-induced hepatic steatosis but aggravates Inflammation in mice. Liver Int. 2020
- E. Halilbasic, E. Fuerst, D. Heiden, L. Japtok, SC. Diesner, M. Trauner, A. Kulu, P. Jaksch, K. Hoetzenecker, B. Kleuser, L. Kazemi-Shirazi, E. Untersmayr. Plasma Levels of the bioactive sphingolipid metabolite S1P in adult cystic fibrosis patients: potential target for immunonutrition? Nutrients 2020; 14:12(3):765
- J. Hammer, M. Sonyi, KM. Engeßer, G. Riedl, Suong, HF. Hammer. Carbohydrate-induced gastrointestinal symptoms: development and Validation of a test-specific symptom questionnaire for an adult Population, the adult Carbohydrate perception questionnaure. Eur J Gastroenterol Hepatol 2020.
- J. Hammer, N. Memaran, WD. Huber, K. Hammer. Development and Validation of the paediatric Carbohydrate Perception Questionnaire (pCPQ) an Instrument for an assessment of carbohydrate induced gastrointestinal symptoms in the paediatric Population. Neurogastroenterol Motil 2020 Jul 1:e13934
- K. Hammer, J. Hammer. Valid Assessment of Carbohydrate Intolerance and the Need for a distinction to carbohydrate malabsorption. Comment on Roles of Lactose and Fructose Malabsorption and Dietary Outcomes in Children Presenting with Chronic Abdominal Pain. Nutrients 2020, 26, 12(6):1546
- K. Jimenez, F. Leitner, A. Leitner, G. Scharbert, P. Schwabl, AM. Kramer, A. Krnjic, J. Friske, T. Helbich, R. Evstatiev, V. Khare, C. Gasche. Iron deficiency induced thrombocytosis increases thrombotic tendency in rats. Haematologica 2020
- M. Kutschera, T. Waldhör, HP. Gröchenig, T: Haas, H. Wenzl, P. Steiner, R. Koch, T. Feichtenschlager, G. Eckhardt, A. Mayer, A. Kirchgatterer, O. Ludwiczek, R: Platzer, P. Papay, J. Gartner, H. Fuchssteiner, PG. Peters, G. Reicht, G. Moser, C. Dejaco, H. Vogelsang, C. Primas, G. Novacek, W. Miehsler. Use of complementary and alternative medicine and low Quality of life associate with the Need for psychological and psyhcotherapeutic interventions in inflammatory bowel disease. United European Gastroenterol J 2020
- M. Lang, M. Baumgartner, A. Rozalska, A. Frick, A. Riva, M. Jarek, D. berry, C. Gasche. Crypt residing bacteria and proximal colonic carcinogenesis in a mouse model of Lynch Syndrome. Int. J. Cancer 2020
- M. Mandorfer, M. Peck Radosavljevic, P. Ferenci, T. Reiberger. Dynamics of platelet Count after sustained virologic Response do not mirror those of hepatic venous pressure Gradient. Liver Int 2020, 40(4):988-989
- M. Mandorfer, K. Kozbial, P. Schwabl, D. Chromy, G. Semmler, AF. Stättermayer, M. Pinter, V. Hernandez Gea, M. Fritzer Szekeres, P. Munda, M. Trauner, M. Peck Radosavljevic, JC. Garcia Pagan, P. Ferenci, T. Reiberger. Change sin hepatic venous pressure Gradient predict hepatic decompensation in patients who achieved sustained virologic Response to interferon-free therapy. Hepatology 2020, 71(3):1023-1036
- M. Mandorfer, V. Hernandez-GEa, JC. Garcia Pagan, T. Reiberger. Noninvasive diagnostics for Portal Hypertension: A comprehensive Review. Semin Liver Dis 2020, 40/3):240-255
- T. Meischl, S. Rasoul Rockenschaub, G. Györi, B. Scheiner, M. Trauner, T. Soliman, G. Berlakovich, M. Pinter. Alpha-Fetoprotein adjusted to HCC size criteria are associated with favourable survival after lung Transplantation for hepatocellular carcinoma. United European Gastroenterol J 2020
- AD Nardo, NG. Grün, M. Zeyda, M. Dumanic, G. Oberhuber, E. Rivelles, Th. Helbich, Df. Markgraf, M. Roden, T. Claudel, M. Strauner, TM. Stulnig. Impact of osteopontin on the development of non-alcohlic liver disease and related hepatocellular carcinoma, Liver Int 2020
- R. Paternostro, J. Pfeiffenberger, P. Ferenci, AF. Stättermayer, RE. Stauber, F. Wrba, Non-invasive diagnosis of cirrhosis and Long-term disease Monitoring by transient elastography in patients with Wilson Disease. Liver Int. 2020, 40(4):894-904
- R. Paternostro, L. Kapzan, M. Mandorfer, R. Schwarzer, S. Benedikt, A. Viveiros, D. Bauer, M. Ferlitsch, H. Zoller, M. Trauner, A. Ferlitsch. Anemia and iron deficiency in compensated and decompensated cirrhosis: Prevalence and Impact on clinical outcomes. J Gastroenterol Hepatol 2020
- M. Peck-Radosavljevic, Digestive health in Europe - lack of concerted Action, exposed by COVID-19 starts with lack of uniform data reporting in liver disease. Infect Dis (Lond) 2020, 52(11):828-829
- M. Pinter, B. Scheiner, M. Peck Radosavljevic, Immunotherapy for advanced hepatocellular carcinoma: a focis on Special subgroups. Gut 2020 Review
- D. Penz, A. Ferlitsch, E. Waldmann, I. Gessl, D. Penz, A. Asaturi, A. Hinterberger, B. Majcher, A. Szymanska, M. Trauner, M. Ferlitsch. Impact of Adenoma detection rate on detection of advanced adenomas and endoscopic adverse Events in a study of over 200.000 Screening colonoscopies. Gastrointest Endosc 2020, 91(1):135-141
- C. Schmidbauer, D. Chromy, V. Schmidbauer, D. Bauer, M. Apata, D. Nguyen, M. Mandorfer, B. Simbrunner, A. Rieger, F. Mayer, R. Schmidt, H. Holzmann, M. Trauner, M. Gschwantler, T. Reiberger. Epidemiological Trends in HCV tansmission and prevalence int he Viennese HIV+ Population. Liver Int. 2020, 40(4):787-796.
- C. Schmidbauer, R. Schubert, A. Schütz, C. Schwanke, J. Luhn, E. Gutic, R. Pirker, T. Lang, T. Reiberger, H. Haltmayer, M. Gschwantler. Directly observed therapy for HCV with glecaprevir/pibrentasvir alongside opoid Substitution in People who inject drugs. First real world data from Austria. Plos One 2020, 15(3):e0229239
- T. Reiberger, P. Schwabl, M. Trauner, M. Peck Radosavljevic, M. Mandorfer. Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy. J Vis Exp 2020
- T. Reiberger, M. Mandorfer. Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient. Hepatology 2020
- J. Stift, K. Semmler, B. Wöran, B. Simbrunner, B. Scheiner, P. Schwabl, R. Paternostro, M. Pinter, AF. Stättermayer, T. Meischl, A. Beer, M. Trauner, M. Mandorfer, T. Reiberger. Comparison of the diagnostic Quality of Aspiration and core biopsy needles for transjugular liver biopsy. Dig Liver Dis 2020
- LW. Unger, B. Forstner, M. Muckenhuber, K. Scheuba, E. Eigenbauer, B. Scheiner, N. Pfisterer, R. Paternostro, M. Trauner, M. Mandorfer,T. Reiberger. Hepatic Steatosis in Lean Patients: Risk Factors and Impact on Mortality. Dig Dis Sci 2020, 65(9):2712-2718
- L. Beer, A. Bastati, A. Ba-Ssalamah, S. Pötter-Lang, K. Lampichler, Y. Bican, D. Lauber, J. Hodge, T. Binter, K. Pomej, B. Simbrunner, G. Semmler, M. Trauner, M. Mandorfer, T. Reiberger. MRI-defined sarcopenia predicts mortality in patients with chronic liver disease. Liver Int. 2020
- W. Reinisch, R. Panaccione, P. Bossuyt, F. Baert, A. Armuzzi, X. hebuterne, S. Travis, S. Danese, WJ. Sandborn, S. Schreiber, S. Berg, Q. Zhou, K. Kligys, E. Neimark, AA. Suleiman, G. D'Haens, JF. Colombel. Association of Biomarker Cutoffs and Endoscopic Outcomes in Crohns Disease: A Post Hoc Analysis from the CALM Study. Inflamm Bowel Dis 2020
- N. Narula, ECL. Wong, PS Dulai, JK Marshall, JF. Colombel, W. Reinisch. Week 6 Calprotectin best predicts likelihood of Long-term endoscopic healing in crohns disease. a post-hoc Analysis of the UNITI/IM-UNITI Trials. J Crohns Colitis 2020
- A. Eser, W. Reinisch, S. Schreiber, T. Ahmad, S. Boulos, DR. Mould. Increased induction infliximab clearance predicts early antidrug antibody detection. J Clin Pharmacol 2020
- W. Reinisch, S. Danese, L. Peyrin-Biroulet, EV. Loftus. Clinical Trials for inflammatory bowel disease: global guidance during teh COVID 19 pandemic. J Crohns Colitis 2020
- N. Narula, ECL. Wong, A. Aruljothy, PS. Dulai, JF: Colombel, JK. Masrshall, M. Ferrante. W. Reinisch. Ileal and rectal ulcer size affects the ability to achieve endoscopic Remission: a post hoc Analysis of the SONIC Trial. Am J Gastroenterol 2020, 115(8):1236-1245
- K. Gottlieb, M. Daperno, K. Usiskin, BE. Sands, H. Ahmad, CW. Howden, W. Karnes, Ys. Oh, I. Modesto, C. Marano, RW. Stidham. W. Reinisch. Endoscopy and central reading in inflammatory bowel disease clinical Trials: achievements, challenges and future developments. Gut 2020
- W. Reinisch, K. Gescse, J. Halfvarson, PM. Irving, J. Jahnsen, L. Peyrin Biroulet, G. Rogler, S. Schreiber, S. Danese. Clinical Practice of adalimumab and infliximab biosimilar Treatment in adult patients with crohns disease. Inflamm Bowel Dis 2020
- W. Reinisch, S. Danese, L. Peyrin Biroulet, EV. Loftus. Clinical Trials for inflammatory bowel disease: a global guidance during COVID 19 pandemic. J Crohns Colitis 2020
- W. Reinisch, DS. Mishkin, YS. Oh, S. Schreiber, F. Hussain, R. Jacob, A. Hassanali, M. Daperno. Impact of various central endoscopy reading models on Treatment outcome in Crohn's disease using data from the randomized, controlled, exploratory cohort arm of the BERGAMOT Trial. Gastrointest Endosc 2020
- M. Samadaei, M. Pinter, D. Senfter, S. Madlener, N. Rohr-Udilova, D. Iwan, K. Kaminska, E. Wojaczynska, J. Wojaczynski, A. Kochel. Synthesis and Cytotoxic activity of chiral sulfonamides based ont he 2-Azabicycloalkane Skeleton. Molecules 2020, 25(10):2355
- S. Scharrer, D. Lissner, C. Primas, W. Reinisch, G. Novacek, S. Reinisch, P.Papay, C. Dejaco, H. Vogelsang, W. Miehsler. Passive Smoking increases the risk for intestinal surgeries in patients with crohns disease. Inflamm Bowel Dis 2020
- B. Scheiner, AF. Stättermayer, P. Schwabl, T. Bucsics, R. Paternostro, D. Bauer, B. Simbrunner, R. Schmidt, R. Marculescu, A. Ferlitsch, M. Peck Radosavljevic, M. Pinter, M. Trauner, T. Reiberger, P. Ferenci, M. Mandorfer. Impact of HSD17B13 rs72613567 genotype on hepatic decomepensation and mortality in patients with Portal Hypertension. Liver Int 2020, 40(2):393-404
- B. Scheiner, G. Semmler, F. Maurer, P. Schwabl, TA. Bucsics, R. Paternostro, D. Bauer, B. Simbrunner, M. Trauner, M. Mandorfer, T. Reiberger, B. Scheiner. Prevalence of and risk factors for anaemia in patients with advanced chronic liver disease. Liver Int 2020, 40(1):194-204
- B. Scheiner, PG. Northup, T. Lisman, M. Mandorfer. Author Response to Letter to the Editor: AB0 von Willebrand factor/factor VIII and Portal vein thrombosis in decompensated cirrhosis. Too late to unmask the culprit ? Liver Int 2020
- B. Scheiner, PG. Northrup, AB. Gruber, G. Semmler, G. Leitner, P. Quehenberger, J. Thaler, C. Ay, M. Trauner, T. Reiberger, T. Lisman, M. Mandorfer. The Impact of ABO blood type on the prevelance of Portal vein thrombosis in patients with advanced chronic liver disease. Liver Int 2020
- B. Scheiner, SD. Baalrud. Mean force kinetic theory applied to self-diffusion in supercritical Lennard-Jones fluids. J Chem Phys. 2020, 152(17):174102
- B. Scheiner, MM. Kirstein, M. Pinter. Reply to the Letter to the Editor Entitled "Too many versus too few platelets in patients with hepatocellular carcinoma: good or bad? Liver Cancer 2020, 9(1):110-111
- B. Scheiner, M. Pinter. Response to the Letter to the Editor concerning the publication "Association of platelet Count and mean platelet volume with Overall survival in patients with cirrhosis and unresectable hepatocellular carcinoma". Liver Cancer 2020, 9(1):107
- R. Schwarzer, T: Reiberger, M. Mandorfer, D. Kivaranovic, S. Hametner, S. Hametner, R. Paternostro, B. Scheiner, J. Schneeweiss-Friedl, M. Trauner, R. Schoefl, A. Maieron. The von Willebrand Factor Antigen to platelet Ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis. J Gastroenterol 2020, 55(5):533-542
- G. Semmler, K. Wöran, B. Scheiner, LW. Unger, R. Paternostro, J. Stift, P. Schwabl, T. Bucsics, D. Bauer, B. Simbrunner, AF. Stättermayer, M. Pinter, M. Trauner, T. Reiberger, M. Mandorfer. Novel reliability criteria for controlled attenuation Parameter assessments for non-invasive evealuation of hepatic steatosis. United European Gastroenterol J 2020, 8(3):321-331
- G. Semmler, T. Binter, K. Kozbial, P. Schwabl, S. Hametner-Schreil, A. Zanetto, S. Gavasso, D. Chromy, DJM Bauer, B. Simbrunner, B. Scheiner, T. Bucsics, AF. Stättermayer, M. Pinter, P. Steindl- Munda, R. Schöfl, FP. Russo, P. Simioni, M. Trauner, P. Ferenci, T. Reiberger, M. Mandorfer. Non-invasive risk stratification after HCV eradication in patients with advanced chronic liver disease. Hepatology 2020
- G. Semmler, B. Scheiner, P. Schwabl, T. Bucsics, R. Paternostro, D. Chromy, Stättermayer AF, M. Trauner, M. Mandorfer, A. Ferlitsch, T. Reiberger. The Impact of hepatic steatosis on Portal Hypertension. Plos One 2019, 14(11):e0224506
- B. Simbrunner, R. Marculescu, B. Scheiner, P. Schwabl, T. Buciscs, A. Stadlman, DJM Bauer, R. Paternostro, E. Eigenbauer, M. Pinter, AF. Stättermayer, M. Trauner, M. Mandorfer, T. Reiberger. Non-invasive detection of Portal Hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease. Liver Int 2020
- B. Simbrunner, A. Beer, K. Wöran, F. Schmitz, C. Primas, M. Wewalka, M. Pinter, W. Dolak, B. Scheiner, A. Püspök, M. Trauner, G. Oberhuber, M. Mandorfer, T. Reiberger. Portal hypertensive gastropathy is associated with iron deficiency anemia. Wien Klin Wochenschr. 2020, 132(1-2)1-11
- AF. Stättermayer, E. Halilbasic, F. Wrba, P. Ferenci, M. Trauner. Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults. J Hep 2020
- AF. Stättermayer, P. Ferenci, M. Trauner. Challenges in understanding the consequences of variants in ABCB4 gene - authors reply. J Hep 2020
- M. Tardelli, VF. Bruschi, CD. Fuchs, T. Claudel, N. Auer, V. Kunczer, M. Baumgartner, AHO Ronda, HJ Verkade, T. Stojakovic, H. Scharnagl, A. Habib, R. Zimmermann, S. Lotersztajn, M. Trauner, Monoacylglycerol Lipase Inhibition protects from liver injury in mouse models of sclerosing cholangitis. Hepatology 2020, 71(5):1750-1765
- M. Tardelli, FV. Bruschi, M. Trauner. The role of metabolic lipases in the pathogenesis and Management of liver disease. Hepatology 2020
- SF. Lax, K SKok, P. Zechner, HH. Kessler, N. Kaufmann, C. Koelbinger, K. Vander, U. Bargfrieder, M. Trauner. Pulmonary arterial thrombosis in COVID-19 with fatal outcome. Results from a prospective, single-Center, clinicopathologic case series. Ann Intern Med 2020
- M. Trauner, C. Chung, RP. Myers, KV. Kowdley. Reply to HEP-20-0140 Letter to the Editors. Could Butyrate be incorporated with farnesoid X receptor Agonist cilofexor to enhance Primary sclerosing cholangitis Treatment? Hepatology 2020
- S. Traussnigg, E. Halilbasic, H. Hofer, P. Munda, T. Stojakovic, G. Fauler, K. Kashofer, M. Krssak, M. Wolzt, M. Trauner. Open-Label Phase II study evaluating safety and efficacy of the non-steroidal farnesoid X receptor Agonist PX-104 in non-alcoholic fatty liver disease. Wien Klin. Wochenschr. 2020
